Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Outpatient Oncology Infusion Market 

5.1. COVID-19 Landscape: Outpatient Oncology Infusion Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Outpatient Oncology Infusion Market, By Product

8.1. Outpatient Oncology Infusion Market, by Product, 2024-2033

8.1.1. Infusion Pumps

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Intravenous Sets

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. IV Cannulas

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. Needleless Connectors

8.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Outpatient Oncology Infusion Market, By Application

9.1. Outpatient Oncology Infusion Market, by Application, 2024-2033

9.1.1. Lung Cancer

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Liver Cancer

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Breast Cancer

9.1.3.1. Market Revenue and Forecast (2021-2033)

9.1.4. Prostate Cancer

9.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Outpatient Oncology Infusion Market, By Therapy 

10.1. Outpatient Oncology Infusion Market, by Therapy, 2024-2033

10.1.1. Chemotherapy

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Targeted Therapy

10.1.2.1. Market Revenue and Forecast (2021-2033)

10.1.3. Immunotherapy

10.1.3.1. Market Revenue and Forecast (2021-2033)

10.1.4. Hormonal Therapy

10.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Outpatient Oncology Infusion Market, By Mode 

11.1. Outpatient Oncology Infusion Market, by Mode, 2024-2033

11.1.1. Intramuscular (IM)

11.1.1.1. Market Revenue and Forecast (2021-2033)

11.1.2. Intravenous (IV)

11.1.2.1. Market Revenue and Forecast (2021-2033)

11.1.3. Subcutaneous

11.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 12. Global Outpatient Oncology Infusion Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2021-2033)

12.1.2. Market Revenue and Forecast, by Application (2021-2033)

12.1.3. Market Revenue and Forecast, by Therapy (2021-2033)

12.1.4. Market Revenue and Forecast, by Mode (2021-2033)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.1.5.2. Market Revenue and Forecast, by Application (2021-2033)

12.1.5.3. Market Revenue and Forecast, by Therapy (2021-2033)

12.1.5.4. Market Revenue and Forecast, by Mode (2021-2033)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.1.6.2. Market Revenue and Forecast, by Application (2021-2033)

12.1.6.3. Market Revenue and Forecast, by Therapy (2021-2033)

12.1.6.4. Market Revenue and Forecast, by Mode (2021-2033)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.2. Market Revenue and Forecast, by Application (2021-2033)

12.2.3. Market Revenue and Forecast, by Therapy (2021-2033)

12.2.4. Market Revenue and Forecast, by Mode (2021-2033)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.5.2. Market Revenue and Forecast, by Application (2021-2033)

12.2.5.3. Market Revenue and Forecast, by Therapy (2021-2033)

12.2.5.4. Market Revenue and Forecast, by Mode (2021-2033)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.6.2. Market Revenue and Forecast, by Application (2021-2033)

12.2.6.3. Market Revenue and Forecast, by Therapy (2021-2033)

12.2.6.4. Market Revenue and Forecast, by Mode (2021-2033)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.7.2. Market Revenue and Forecast, by Application (2021-2033)

12.2.7.3. Market Revenue and Forecast, by Therapy (2021-2033)

12.2.7.4. Market Revenue and Forecast, by Mode (2021-2033)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2021-2033)

12.2.8.2. Market Revenue and Forecast, by Application (2021-2033)

12.2.8.3. Market Revenue and Forecast, by Therapy (2021-2033)

12.2.8.4. Market Revenue and Forecast, by Mode (2021-2033)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.2. Market Revenue and Forecast, by Application (2021-2033)

12.3.3. Market Revenue and Forecast, by Therapy (2021-2033)

12.3.4. Market Revenue and Forecast, by Mode (2021-2033)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.5.2. Market Revenue and Forecast, by Application (2021-2033)

12.3.5.3. Market Revenue and Forecast, by Therapy (2021-2033)

12.3.5.4. Market Revenue and Forecast, by Mode (2021-2033)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.6.2. Market Revenue and Forecast, by Application (2021-2033)

12.3.6.3. Market Revenue and Forecast, by Therapy (2021-2033)

12.3.6.4. Market Revenue and Forecast, by Mode (2021-2033)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.7.2. Market Revenue and Forecast, by Application (2021-2033)

12.3.7.3. Market Revenue and Forecast, by Therapy (2021-2033)

12.3.7.4. Market Revenue and Forecast, by Mode (2021-2033)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2021-2033)

12.3.8.2. Market Revenue and Forecast, by Application (2021-2033)

12.3.8.3. Market Revenue and Forecast, by Therapy (2021-2033)

12.3.8.4. Market Revenue and Forecast, by Mode (2021-2033)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.2. Market Revenue and Forecast, by Application (2021-2033)

12.4.3. Market Revenue and Forecast, by Therapy (2021-2033)

12.4.4. Market Revenue and Forecast, by Mode (2021-2033)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.5.2. Market Revenue and Forecast, by Application (2021-2033)

12.4.5.3. Market Revenue and Forecast, by Therapy (2021-2033)

12.4.5.4. Market Revenue and Forecast, by Mode (2021-2033)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.6.2. Market Revenue and Forecast, by Application (2021-2033)

12.4.6.3. Market Revenue and Forecast, by Therapy (2021-2033)

12.4.6.4. Market Revenue and Forecast, by Mode (2021-2033)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.7.2. Market Revenue and Forecast, by Application (2021-2033)

12.4.7.3. Market Revenue and Forecast, by Therapy (2021-2033)

12.4.7.4. Market Revenue and Forecast, by Mode (2021-2033)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2021-2033)

12.4.8.2. Market Revenue and Forecast, by Application (2021-2033)

12.4.8.3. Market Revenue and Forecast, by Therapy (2021-2033)

12.4.8.4. Market Revenue and Forecast, by Mode (2021-2033)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.5.2. Market Revenue and Forecast, by Application (2021-2033)

12.5.3. Market Revenue and Forecast, by Therapy (2021-2033)

12.5.4. Market Revenue and Forecast, by Mode (2021-2033)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2021-2033)

12.5.5.2. Market Revenue and Forecast, by Application (2021-2033)

12.5.5.3. Market Revenue and Forecast, by Therapy (2021-2033)

12.5.5.4. Market Revenue and Forecast, by Mode (2021-2033)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2021-2033)

12.5.6.2. Market Revenue and Forecast, by Application (2021-2033)

12.5.6.3. Market Revenue and Forecast, by Therapy (2021-2033)

12.5.6.4. Market Revenue and Forecast, by Mode (2021-2033)

Chapter 13. Company Profiles

13.1. B. Braun Melsungen AG

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Baxter

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Becton

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Dickinson and Company

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Fresenius Kabi

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. ICU Medical, Inc

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. IRadimed Corporation

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Nipro Corporation

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Terumo Corporation.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Smith's Medical

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms